Cargando…
Metformin Ameliorates Lipopolysaccharide-Induced Depressive-Like Behaviors and Abnormal Glutamatergic Transmission
SIMPLE SUMMARY: Metformin is a promising drug for diabetes and has been reported to have antidepressant effects in depression patients or patients with comorbid depression and other diseases. However, it is largely unclear how metformin ameliorates depressive-like behaviors. To this end, we injected...
Autores principales: | Chen, Jiang, Zhou, Tian, Guo, A-Min, Chen, Wen-Bing, Lin, Dong, Liu, Zi-Yang, Fei, Er-Kang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7692296/ https://www.ncbi.nlm.nih.gov/pubmed/33114529 http://dx.doi.org/10.3390/biology9110359 |
Ejemplares similares
-
Metformin Enhances Excitatory Synaptic Transmission onto Hippocampal CA1 Pyramidal Neurons
por: Chen, Wen-Bing, et al.
Publicado: (2020) -
Resveratrol Ameliorates the Depressive-Like Behaviors and Metabolic Abnormalities Induced by Chronic Corticosterone Injection
por: Li, Yu-Cheng, et al.
Publicado: (2016) -
Forebrain glutamatergic neurons mediate leptin action on depression-like behaviors and synaptic depression
por: Guo, M, et al.
Publicado: (2012) -
Dysfunction of Glutamatergic Synaptic Transmission in Depression: Focus on AMPA Receptor Trafficking
por: He, Jin-Gang, et al.
Publicado: (2022) -
Lysophosphatidic Acid and Glutamatergic Transmission
por: Roza, Carolina, et al.
Publicado: (2019)